ANGO vs SLB · rev $292.5M vs P/E 12, rev $35.71B
AngioDynamics Inc (ANGO) versus Schlumberger NV (SLB) — a side-by-side from cached financials, not a winner call.
AngioDynamics Inc (ANGO) is a medical instruments & supplies company listed on US.
Schlumberger NV (SLB) is a oil & gas equipment & services company listed on US.
Latest reported ANGO revenue for 2025-05-31 was $292.5M. Net income was -$34.0M. Revenue was down 3.8% from 2024-05-31 to 2025-05-31. ANGO currently screens at market cap $378.5M.
Latest reported SLB revenue for 2025-12-31 was $35.71B. Net income was $3.37B. Revenue was down 1.6% from 2024-12-31 to 2025-12-31. SLB currently screens at market cap $48.16B and trailing P/E 12.1.
ANGO currently screens at market cap $378.5M. SLB currently screens at market cap $48.16B and trailing P/E 12.1.
Not investment advice. Open the ANGO and SLB stock pages for the full models.
Not investment advice.